|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Interest income | |||||
| Financial assets at FVTPL | |||||
| Financial assets at FVTOCI | |||||
| Financial assets at amortized cost | |||||
| Insurance finance | |||||
| Interest expense | |||||
| Financial liabilities at amortized cost | |||||
| Total | |||||
| Fees and commissions income | |||||
| Fees and commissions expense | |||||
| Net fees and commissions income | |||||
| Dividend income | |||||
| Insurance income | |||||
| Insurance | |||||
| Reinsurance | |||||
| Insurance service expense | |||||
| Insurance service | |||||
| Reinsurance service | |||||
| Net insurance income | |||||
| Other insurance finance income and expenses | |||||
| Net gain on financial instruments at FVTPL | |||||
| Net gain (loss) on financial assets at FVTOCI | |||||
| Net gain arising on financial assets at amortized cost (Note 11) | |||||
| Net gain arising on financial assets at amortized cost | |||||
| Impairment losses due to credit loss | |||||
| General and administrative expenses | |||||
| Other net operating expense | |||||
| Operating income | |||||
| Share of gain of joint ventures and associates | |||||
| Other non-operating income (expense) | |||||
| Non-operating income (expense) | |||||
| Net income before income tax expense | |||||
| Income tax expense | |||||
| Net income | |||||
| Other comprehensive income [abstract] | |||||
| Net gain (loss) on valuation of equity securities at FVTOCI | |||||
| Net gain on credit risk fluctuation of financial liabilities designated to be measured at FVTPL | |||||
| Changes in capital due to equity method | |||||
| Remeasurement loss related to defined benefit liabilities | |||||
| Items that will not be reclassified to profit or loss | |||||
| Net gain (loss) on valuation of debt securities at FVTOCI | |||||
| Net gain (loss) on foreign currency translation of foreign operations | |||||
| Net gain (loss) valuation of hedges of net investments in foreign operations | |||||
| Net gain (loss) on valuation of cash flow hedge | |||||
| Net financial gain on insurance contract assets (liabilities) | |||||
| Net financial loss on reinsurance contract assets (liabilities) | |||||
| Items that may be reclassified to profit or loss | |||||
| Other comprehensive income(loss), net of tax | |||||
| Total comprehensive income | |||||
| Net income attributable to: | |||||
| Net income attributable to shareholders | |||||
| Net income attributable to non-controlling interests | |||||
| Total comprehensive income attributable to: | |||||
| Comprehensive income attributable to shareholders | |||||
| Comprehensive income attributable to non-controlling interests | |||||
| Earnings per share | |||||
| Basic earnings per share | |||||
| Diluted earnings per share | |||||
Loading...